Zydus Lifesciences Limited (ZYDUSLIFE-NS) Stock Split, History Data
Working capital analysis
In terms of working capital, Zydus Lifesciences Limited maintains a healthy position.
The total current assets of the company are valued at $100164000000.
This represents a growth rate of -18.309% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $4878000000, exhibiting a growth rate of -25.844% year-on-year.
The receivables, another significant portion of the current assets, are valued at $44254000000.
The year-on-year growth rate for receivables is -12.062%.
The inventory, which forms a critical part of the assets, is valued at $34133000000.
This represents a healthy year-on-year growth of -8.230%
On the liabilities side, the company's current liabilities total $55307000000.
This reflects a growth rate of -29.450% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
4878.00
6578.00
6652.00
8453.00
4207.00
13149.00
Receavebles
44254.00
50324.00
43498.00
45779.00
47563.00
36290.00
Inventory
34133.00
37194.00
32362.00
27890.00
26880.00
23853.00
Other
7573.00
48.00
28.00
89.00
534.00
4233.00
Total Current Assets
100164.00
122614.00
87160.00
87154.00
84981.00
82297.00
Acc Payable
21250.00
21378.00
22059.00
20310.00
19226.00
18884.00
Short Term Debt
11751.00
38427.00
39830.00
47847.00
39497.00
28516.00
Other Current Liab
2705.00
345.00
241.00
164.00
203.00
211.00
Current Liabilities
55307.00
78394.00
78613.00
82694.00
73425.00
59828.00
Capital Structure
When examining the capital structure of Zydus Lifesciences Limited, it is clear that the company manages a robust portfolio.
On the asset side, the cash and equivalent reserves are worth $-15195000000.
The year-on-year growth of these reserves is -13.057%.
These earnings represent the profits that Zydus Lifesciences Limited has chosen to reinvest in the business rather than distribute as dividends.
Total Assets
$0.00
Total liabilities
$0.00
Long term debt
$0.00
Cash and eqv
-$15,195,000,000.00
Goodwill
$0.00
Retained earnings
$0.00
Common stock
$1,024.00
Enterprise Value
$18.53
Historical dividend key summary
Zydus Lifesciences Limited's dividend per share is $6, showing the earnings shared with shareholders per share. It has grown by 140.000% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.
Years
Q1
Q2
Q3
Q4
Total
2023
0.000
0.000
6.000
0.000
6.000
2022
0.000
0.000
2.500
0.000
2.500
2021
0.000
0.000
3.500
0.000
3.500
2020
0.000
3.500
0.000
0.000
3.500
2019
0.000
0.000
3.500
0.000
3.500
2018
0.000
0.000
3.500
0.000
3.500
2017
0.000
3.200
0.000
0.000
3.200
2016
3.200
0.000
0.000
0.000
3.200
2015
0.000
0.000
2.400
0.000
2.400
2014
0.000
0.000
1.800
0.000
1.800
2013
0.000
1.500
0.000
0.000
1.500
2012
0.000
0.000
1.500
0.000
1.500
2011
0.000
0.000
1.250
0.000
1.250
2010
0.000
0.000
1.000
0.000
1.000
2009
0.000
0.000
0.600
0.000
0.600
2008
0.000
0.000
0.600
0.000
0.600
2007
0.000
0.000
0.533
0.000
0.533
2006
0.000
0.000
0.800
0.000
0.800
2005
0.000
0.000
0.800
0.000
0.800
2004
0.000
0.000
0.800
0.000
0.800
2003
0.000
0.000
0.467
0.000
0.467
2002
0.000
0.000
0.467
0.000
0.467
2001
0.000
0.400
0.000
0.000
0.400
2000
0.000
0.400
0.000
0.000
0.400
Net earnings per share (EPS)
Zydus Lifesciences Limited has an EPS of $29.38, which signifies the profit allocated per share of common stock. With a growth rate of 45.086% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.
Years
Q1
Q2
Q3
Q4
Total
2023
10.74
7.91
7.8
2.93
29.38
2022
5.06
5.16
6.15
3.88
20.25
2021
5.74
29.33
4.89
6.63
46.59
2020
4.43
5
5.15
3.83
18.41
2019
2.97
1.05
3.65
4.5
12.17
2018
4.5
4.08
4.99
5.77
19.34
2017
1.35
4.92
5.31
3.77
15.35
2016
3.89
3.71
3.16
5.59
16.35
2015
4.5
4.64
4.21
3.4
16.75
2014
2.35
2.72
2.75
2.34
10.16
2013
1.91
1.79
1.82
2.55
8.07
2012
1.9
0.92
1
1.67
5.49
2011
-
1
1.46
-
2.46
Brief information
Zydus Lifesciences Limited (ZYDUSLIFE.NS) stock split history
Understanding the historical stock splits of Zydus Lifesciences Limited (ZYDUSLIFE.NS) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on October 06, 2015 with a ratio of 5:1. Throughout its history, the company has undergone 2 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.
